Early vs Late ESA for Anemia in Lower Risk MDS
EPO-PRETAR: Phase III Trial of Early vs Late Initiation of ESA Treatment in Patients With Lower-Risk MDS and Anemia

Released: December 10, 2024

Expiration: December 09, 2025

Activity

Progress
1
Course Completed